Interesting. I have a completely different take.On adding...

Interesting. I have a completely different take.

On adding "absolutely no value", I disagree. I think it's a solid strategic move to align the company's identity with its evolving vision and goals. In my opinion, Antisense Therapeutics is a terrible company name that we've all become comfortable with. I'd wager that if you A/B tested the two names with people that have never heard of us (basically everyone), Percheron Therapeutics would absolutely crush Antisense Therapeutics in every area, especially trustability.

On the search term "antisense", this should tell you how important it is:

https://trends.google.com/trends/explore?date=today%205-y&q=Antisense&hl=en-GB

(not at all).

Further to that:
- it's only the top result under certain conditions (searching from Australia and/or whilst logged into an Australian Google account)
- we'd likely hold onto the domain name

On the topic of Facebook/Twitter, we're a completely unknown, small cap biotech stock. There is no brand reputation/recognition being jettisoned here. On the contrary, congnitive bias is real and the word "anti" has negative connotations.

Cheers and good luck!